Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy
about
Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?Vitamin intake reduce the risk of gastric cancer: meta-analysis and systematic review of randomized and observational studiesRole of bacteria in oncogenesisCurrent concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportDietary antioxidants protect gut epithelial cells from oxidant-induced apoptosisGastrointestinal stem cells in health and disease: from flies to humansDiagnosis and management of gastric dysplasiaRole of Helicobacter pylori in gastric cancer: UpdatesRole of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directionsHereditary diffuse gastric cancer: What the clinician should knowMolecular cancer prevention: Current status and future directionsGastric cancer: prevention, risk factors and treatmentGastric cancer: prevention, screening and early diagnosisHistological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysisVitamin C, gastritis, and gastric disease: a historical review and updateGastric cáncer: Overview.Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasiaSecondary prevention of gastric cancerDynamics of Lewis b binding and sequence variation of the babA adhesin gene during chronic Helicobacter pylori infection in humansManagement of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade PortuDietary factors modulate Helicobacter-associated gastric cancer in rodent modelsHelicobacter pylori eradication for preventing gastric cancerRelationship between H.Pylori infection and clinicopathological features and prognosis of gastric cancer.Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trialsEpidemiology of gastric cancer.Recent developments in gastroenterology.A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer.At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.Adenocarcinoma of the stomach: a review.Recombination and mutation during long-term gastric colonization by Helicobacter pylori: estimates of clock rates, recombination size, and minimal age.Pathology of gastric intestinal metaplasia: clinical implications.Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections.Approach to Helicobacter pylori infection in geriatric population.Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensusGastric microbiome and gastric cancerHelicobacter pylori and gastric cancer: factors that modulate disease risk.P53 Codon 72 polymorphisms: a case-control study of gastric cancer and potential interactions.Prevention of Gastric Cancer: When is Treatment of Helicobacter Pylori Warranted?Diet, H pylori infection and gastric cancer: evidence and controversies.Effect of smoking on failure of H. pylori therapy and gastric histology in a high gastric cancer risk area of Colombia
P2860
Q21090716-539F1905-8EC7-4B7D-819B-08DD088D1136Q21559519-308B605F-B98E-4A05-9026-8D5F28B6E37AQ24633180-F42A0FF4-D31A-4943-9C5B-95E63257C6ECQ24674636-054BFCB9-F747-4BCA-B29A-D4B1ED7ACADBQ24797247-A7277C77-1CE7-4BCB-AFA7-E7A30C7D1E14Q26750514-516438A6-7837-459C-B587-D92C3AF81C37Q26765128-0350C6E3-AE20-4996-ADC5-085ABEFCEE2FQ26766696-D10F0509-F381-453F-9592-B8CF1D6D0B91Q26778023-855514ED-10A3-4A59-8282-05E5AEC3606DQ26784215-F5CFD60C-EF1D-4C09-B45E-0A771E54D82EQ26797207-0271F853-E74E-4FA2-81F8-F035FC1AFA7BQ26828903-2671DB1D-C345-44E2-A30E-364E8A69A2D6Q26860418-DB831B7A-A4A7-468D-9015-F440EE891526Q26864431-8C657CF8-3A10-4C7B-AA41-BD2B87477DD5Q26993219-0F5333FC-8749-43E3-BB50-A645F433BF69Q27692548-D700CBA5-9592-4307-B04C-CB84A92E9567Q28367045-8FD5FE5B-6104-4D33-A50E-F7D32B3303C9Q28756632-08E00B6E-9C30-47C6-B444-D2D0FC09BBD5Q30153266-65603649-E4E8-4AAB-932C-C0B825BA3670Q30426539-1BBBDD33-F7F8-43BD-BE55-B5763623E490Q33621846-017EABC1-1606-40CE-AF8B-2DB6CCE1DB93Q33626785-4C3C8AEF-BDEB-4B53-A00B-6575BEE4C82BQ33634680-41E0D60B-C7D3-4DD7-AFA6-50AD6D252257Q33636554-F1F679E4-E2C2-414F-8BB7-9EA15E59CDEAQ33788193-024D191C-2C4D-4A57-A5E3-B3B62E12D8F2Q33813304-B2490E14-C8D4-4A27-AA86-9FA67CAB4A58Q33822961-F8200EA4-B1EC-4E32-87EF-AAD313A2940FQ33911623-357E3B8B-2075-4E05-88FC-9EAF042C7ADCQ33944994-0D286C9D-5EA8-45CF-92E1-96F7510B8D50Q33952890-ED41519B-1C37-4CE1-AD98-7235717DF671Q33954445-54950E40-A506-4E64-8187-D339168F6589Q33998494-971C2933-B1BD-40D3-8F10-C292CF30E181Q34047658-EE4A1388-9077-4685-A11A-8B111A470C9AQ34067951-3276A86E-1BCD-45D8-932C-89DFDC662428Q34109460-31EEDFBD-8C81-49CE-9D92-2554F7D0BB7DQ34189885-D52930C0-15F6-4461-A0FB-C35A84150310Q34194142-0F306745-183E-452C-9D76-15CEF58F941AQ34197057-31B29B0B-3447-4E31-AA5A-05EBEA23EFBAQ34224689-CC342F1E-768B-413A-99B3-D804C7510484Q34273800-0E1D7141-AD9B-4118-9793-8CE5FC4E70F8
P2860
Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy
description
im Dezember 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 December 2000
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2000
@uk
name
Chemoprevention of gastric dys ...... ti-helicobacter pylori therapy
@en
Chemoprevention of gastric dys ...... ti-helicobacter pylori therapy
@nl
type
label
Chemoprevention of gastric dys ...... ti-helicobacter pylori therapy
@en
Chemoprevention of gastric dys ...... ti-helicobacter pylori therapy
@nl
prefLabel
Chemoprevention of gastric dys ...... ti-helicobacter pylori therapy
@en
Chemoprevention of gastric dys ...... ti-helicobacter pylori therapy
@nl
P2093
P356
P1476
Chemoprevention of gastric dys ...... ti-helicobacter pylori therapy
@en
P2093
E T Fontham
G T Malcom
J L Realpe
P304
P356
10.1093/JNCI/92.23.1881
P407
P50
P577
2000-12-01T00:00:00Z